Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2003
12/18/2003WO2003025149A3 Cell populations which co-express cd49c and cd90
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003WO2003006045A3 Cxcl10 treatment of secondary tissue degeneration
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002097045A3 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/18/2003WO2002092788A3 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
12/18/2003WO2002092781A3 Peptide compounds for counteracting reactive oxygen species and free radicals
12/18/2003WO2002090375A3 Liver x receptor agonists
12/18/2003WO2002079456B1 A method for the preparation of immunologically inert amniotic membranes
12/18/2003WO2002067916A3 Pharmaceutical salts
12/18/2003WO2002062398A3 Radioactively labelled conjugates of phosphonates
12/18/2003WO2002060871A8 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
12/18/2003WO2002058723A3 Chemokines as adjuvants of immune response
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003WO2002014536A9 Odulating multiple lineage kinase proteins
12/18/2003WO2002007678A3 Mu-conopeptides
12/18/2003US20030233086 Drug delivery system for conscious sedation
12/18/2003US20030233035 Methods and devices for diagnosing and treating choroid plexus failure
12/18/2003US20030233015 Sulfonamide derivatives
12/18/2003US20030232986 Inhibitors of caspases
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232889 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain
12/18/2003US20030232883 N-acylamino benzyl ether derivatives
12/18/2003US20030232880 For therapy of pain, fever or inflammation to inhibit prostanoid-induced smooth muscle contraction; for prophylaxis and therapy of colorectal cancer or neurodegenerative diseases
12/18/2003US20030232877 1,3-Bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
12/18/2003US20030232868 Cyclic carboxylic acids as integrin antagonists
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232857 Side effects reduction; for treating nervous system disorders (attention deficit/hyperactivity, and cognitive decline associated with acquired immunodeficiency syndrome)
12/18/2003US20030232853 Azabicyclic compounds for the treatment of disease
12/18/2003US20030232849 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/18/2003US20030232847 Imidazo-substituted compounds as p38 kinase inhibitors
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232841 Amides such as 5-(2-(4-methylpiperazin-1-yl)-phenyl)-furan-2-carboxylic acid 4-chlorobenzylamide, used as antidepressants and for prophylaxis of headaches
12/18/2003US20030232839 Administering heterocyclic amines, as controllers of central nervous system(CNS) such as serotonin receptors
12/18/2003US20030232833 Benzofuran derivatives
12/18/2003US20030232828 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
12/18/2003US20030232827 Therapeutic compounds
12/18/2003US20030232825 Benzoxazine derivatives and uses thereof
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232822 Ht3 receptor antagonists
12/18/2003US20030232819 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions
12/18/2003US20030232815 Non-peptidic cyclophilin binding compounds and their use
12/18/2003US20030232814 Novel compounds and their use
12/18/2003US20030232813 Novel amino substituted pyrimidinone derivatives
12/18/2003US20030232810 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
12/18/2003US20030232805 Administering a dual serotonin/norepinephrine reuptake inhibitor or a triple monoamine reuptake inhibitor for serotonin/noradrenaline/ dopamine
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003US20030232796 Nanoparticulate polycosanol formulations & novel polycosanol combinations
12/18/2003US20030232795 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity
12/18/2003US20030232788 Inhibitors of interleukin-1 beta converting enzyme and related proteases
12/18/2003US20030232783 Partial and full agonists of A1 adenosine receptors
12/18/2003US20030232763 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors
12/18/2003US20030232752 Proliferated cell lines and uses thereof
12/18/2003US20030232741 Methods of treatment of glaucoma and other conditions mediated by NOS-2 expression via inhibition of the EGFR pathway
12/18/2003US20030232739 Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist
12/18/2003US20030232430 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232099 Powder and an extract of lotus root joints; improves insulin resistance, for diabetes, obesity, hyperlipidemia, hypertension, thrombosis, Alzheimer's disease and senility
12/18/2003US20030232078 Formulation & dosage form for the controlled delivery of therapeutic agents
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2490357A1 Gene therapeutic for cerebrovascular disorders
12/18/2003CA2488801A1 Ether substituted imidazopyridines
12/18/2003CA2488798A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488691A1 Extended release formulation of divalproex sodium
12/18/2003CA2488617A1 Nanoparticulate sterol formulations and sterol combinations
12/18/2003CA2488613A1 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003CA2488609A1 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
12/18/2003CA2488602A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488498A1 Nanoparticulate polycosanol formulations and novel polycosanol combinations
12/18/2003CA2488497A1 Neuroprotective synergy of erythropoietin and insulin-like growth factor
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2488108A1 Liquid formulation of decitabine and use of the same
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2487077A1 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003CA2486581A1 Substituted phenylsulfonamide inhibitors of beta amyloid production
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2485874A1 T cell receptor cdr3 sequences and methods for detection
12/18/2003CA2485725A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003CA2484514A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/17/2003EP1371650A1 Activator for peroxisome proliferator-activated receptor
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1371367A1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
12/17/2003EP1371366A1 Methods for the prevention and/or the treatment of neurological disorders
12/17/2003EP1371289A1 Choline-silicic acid complex
12/17/2003EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370655A2 Secreted human proteins
12/17/2003EP1370647A2 A dna molecule encoding a variant paraoxonase and uses thereof
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370568A1 Chemical compounds
12/17/2003EP1370562A1 Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors
1 ... 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 ... 1833